Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Agios Pharmaceuticals Stock Quote

Agios Pharmaceuticals (NASDAQ: AGIO)

Price as of May 22, 2024, 4:00 p.m. ET

Agios Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AGIO +23.30% -30.81% -7.10% +8%
S&P +26.92% +88.55% +13.52% +216%

Agios Pharmaceuticals Company Info

Agios Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.